Lux Michael P, Hildebrandt Thomas, Knetzger Sandra-Maria, Schrauder Michael G, Jud Sebastian M, Hein Alexander, Rauh Claudia, Fasching Peter A, Beckmann Matthias W, Thiel Falk C
Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany.
BMC Cancer. 2015 Aug 14;15:587. doi: 10.1186/s12885-015-1584-3.
Medical research studies are becoming increasingly important for optimizing the prevention, diagnosis and treatment of illnesses. Participation in research studies can have many benefits for patients. In randomized and controlled clinical studies, they can receive the best possible medical care currently available. However, only a small proportion of patients nowadays are treated within the framework of medical research. The primary endpoint of this study was to discover what level of knowledge patients have about clinical studies and how they currently perceive them, in order to identify ways of optimizing the information provided about studies from the patients' point of view.
The study included 2546 patients (breast cancer 21.6%, gynecological cancer 8.3%, obstetrics 32.7%, endometriosis 7.8%, fertility treatment 3.2%, other benign gynecological illnesses 19.2%, no information for 7.2%) in the outpatient clinic (45.2%) and in the in-patient sector (54.8%) at the Department of Gynecology at Erlangen University Hospital and associated centers. In the single-center study, conducted between January 2011 and January 2012, the patients were asked about their level of knowledge regarding the background to medical research studies and the ways in which they are carried out and used. The patients were also asked how they perceived medical studies and how they thought study conditions might be optimized. The three-page questionnaire was included in the feedback sheet received by patients as part of the hospital's quality management system.
As a whole, the group only had moderate knowledge about clinical studies. A majority of the respondents considered that studies were valuable (91.6%), but only a few were also willing to take part in them (58.4%). Knowledge and willingness to participate strongly depended on age (P < 0.001), educational level (P < 0.001) and patient group (P < 0.001). Most patients would prefer to decide about participating in studies through a discussion with their outpatient physicians.
The information that patients have about clinical studies affects whether they participate in them. It is therefore extremely important for patients to be well informed, for their anxieties about participation to be relieved, and for the benefits of participation to be explained to them.
医学研究对于优化疾病的预防、诊断和治疗愈发重要。参与研究对患者可能有诸多益处。在随机对照临床研究中,患者能获得当前可得的最佳医疗护理。然而,如今仅有一小部分患者在医学研究框架内接受治疗。本研究的主要终点是了解患者对临床研究的认知水平以及他们当前对临床研究的看法,以便从患者角度确定优化研究信息提供方式的方法。
该研究纳入了埃尔朗根大学医院妇科及相关中心门诊(45.2%)和住院部(54.8%)的2546名患者(乳腺癌21.6%、妇科癌症8.3%、产科32.7%、子宫内膜异位症7.8%、生育治疗3.2%、其他良性妇科疾病19.2%、无信息7.2%)。在2011年1月至2012年1月进行的单中心研究中,询问了患者关于医学研究背景、开展和应用方式的知识水平。还询问了患者对医学研究的看法以及他们认为如何优化研究条件。这份三页的问卷包含在患者作为医院质量管理系统一部分收到的反馈表中。
总体而言,该群体对临床研究的了解程度一般。大多数受访者认为研究有价值(91.6%),但只有少数人也愿意参与(58.4%)。知识水平和参与意愿强烈依赖于年龄(P < 0.001)、教育程度(P < 0.001)和患者群体(P < 0.001)。大多数患者更愿意通过与门诊医生讨论来决定是否参与研究。
患者对临床研究的了解会影响他们是否参与。因此,让患者充分了解信息、缓解他们对参与的担忧并向他们解释参与的益处极为重要。